ReviewCell biochemistry and biophysics2026
The Reductive Stress Nexus: Integrated Pathways of Metabolic Dysregulation, Senescence and Blood-Brain Barrier Failure in Neurodegenerative Disease and Brain Aging.
Review in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Reductive stress refers to a pathological shift toward a more reduced state in one or more defined redox couples, including NAD+/NADH, NADP+/NADPH, and GSSG/GSH, within specific cellular or subcellular compartments. Low-molecular-weight (LMW) thiols, including cysteine, cysteamine, glutathione, homocysteine, and hydrogen sulfide, contribute to cellular redox buffering, thiol-disulfide exchange, and redox-dependent metabolic regulation. Under chronic activation of antioxidant enzymatic systems, expansion of the reduced thiol pool may shift redox homeostasis toward a hyperreduced state, suppress physiological ROS-dependent signaling, and impair protein thiol-disulfide regulation. This review examines the cellular and molecular mechanisms of reductive stress within the neurovascular unit, the functional complex comprising microcapillary endothelial cells, pericytes, astrocytes, and neurons that maintains blood-brain barrier integrity and metabolic coupling. A reductive imbalance disrupts physiological redox signaling, impairs mitochondrial function, induces endoplasmic reticulum stress and the unfolded protein response (UPR), dysregulates ion channels and calcium homeostasis, promotes DNA damage, and activates cellular senescence programs and inflammasomes. Critically, reductive stress is not isolated but forms an integrated pathological network with oxidative, nitrosative, and glycation stresses, creating a self-sustaining cycle of mitochondrial dysfunction, macromolecular damage, and chronic neuroinflammation. Particular attention is given to compartment-specific redox regulation by mitochondrial glutathione and the peroxiredoxin/thioredoxin system, the dual role of ROS as physiological second messengers and mediators of secondary oxidative injury, and the links between hyperreduction, cellular senescence, AGE/RAGE signaling, and BBB dysfunction. We emphasize that reliable identification of reductive stress requires the simultaneous, compartment-resolved assessment of several redox couples and their functional consequences. This review also summarizes experimental approaches for modeling and detecting reductive stress and discusses emerging therapeutic strategies, including xenotopic enzymes, genetically encoded metabolic tools, and NAD+ modulation, aimed at restoring redox homeostasis and slowing neurodegeneration and aging.
Indexed as
Identifiers
42645669What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.